Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MOTIF@FRESH: VMT for Recurrent Bacterial Vaginosis
NCT07566754Phase 2Not yet recruiting
- Start
- Sep 2026
- Primary completion
- May 2027
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of vaginal flora transplant in bacterial vaginosis (BV). Planned start Sep 2026; status: not yet recruiting.
02
Drugs
vaginal flora transplant
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on NCT07566754.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07566754.